Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy
Figure 1
Representative blood glucose profiles before treatment. Blood glucose profile and the dose of each insulin injection are shown (a). The duration between ticks on the X-axis represents 24 h. The frequency of hypoglycemia, defined as below 70 mg/dL of blood glucose, is shown (b).
